Douglas Fambrough's Net Worth

$11.4 Million

Estimate Recalculated Sep 8, 2024 07:29PM EST

Who is Douglas Fambrough?

Douglas Fambrough has an estimated net worth of $11.4 Million. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, Oncorus, Inc., Solexa, Inc., and SIRNA THERAPEUTICS INC.

SEC CIK

Douglas Fambrough's CIK is 0001259856

Past Insider Trading and Trends

2021 was Douglas Fambrough's most active year for acquiring shares with 7 total transactions. Douglas Fambrough's most active month to acquire stocks was the month of December. 2021 was Douglas Fambrough's most active year for disposing of shares, totalling 19 transactions. Douglas Fambrough's most active month to dispose stocks was the month of November. 2021 saw Douglas Fambrough paying a total of $710,466.80 for 521,265 shares, this is the most they've acquired in one year. In 2021 Douglas Fambrough cashed out on 2,864,838 shares for a total of $9,199,170.26, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Dicerna Pharmaceuticals Inc No price found

Chief Executive Officer

Douglas Fambrough used to own units in Common Stock but no longer holds any shares there.acquired a total of 358,465 shares in Dicerna Pharmaceuticals Inc at a cost of $1,402,662.80, Douglas also disposed a total of 381,959 shares of Dicerna Pharmaceuticals Inc equalling to $12,813,101.34.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-231.43K
$38.25
-$8,852,235.75
0
Dec 28
Form 4
+3.77%
8.4K
$38.05
-$203,491.40
231.43K
Dec 15
Form 4
+416.70%
179.87K
$3.34
$599,986.80
223.03K
Dec 10
Form 4
+13.10%
5K
$22.10
$110,480.00
43.16K
Aug 10
Form 4
+59.34%
13.79K
$23.29
-$143,443.11
37.03K
Jan 8 - Jan 12
Form 4
+81.30%
10K
$18.06
$180,597.00
22.3K
Sep 1
Form 4
—
0
—
—
0
Jan 8
Form 4
-82.75%
-59.02K
$14.71
-$3,340,331.08
12.3K
Dec 17 - Dec 18
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Jan 3
Form 4
+147.25%
33.1K
$3.71
$122,643.00
55.58K
Nov 14 - Nov 15
Form 4
—
0
—
—
0
Jan 8
Form 4
—
0
—
—
0
Jan 9
Form 4
+14.45%
2.5K
$3.42
$8,550.00
19.8K
Dec 17
Form 4
—
0
—
—
0
Apr 16
Form 4
+476.67%
14.3K
$7.47
$106,806.00
17.3K
Sep 24 - Jan 29
Form 3
—
0
—
—
0
No matching records found

Oncorus, Inc. (ONCR) Snapshot price: $0.126

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 22
Form 3
—
0
—
—
0
No matching records found

Solexa, Inc. No price found

Investor

Douglas Fambrough owns 1,559 units of Common Stock. In the year 2005 Douglas Fambrough filed a total of 3 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.56K
$10.74
$16,743.66
1.56K
Jan 13
Form 4
—
0
—
—
0
Sep 6
Form 3
—
0
—
—
0
No matching records found

SIRNA THERAPEUTICS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 29
Form 4
—
0
—
—
0
Aug 1
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Aug 12
No matching records found